Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Treasury Shares: 2010-2024

Historic Treasury Shares for Pediatrix Medical (MD) over the last 15 years, with FY2024 value amounting to $1.7 million.

  • Pediatrix Medical's Treasury Shares rose 65000.0% to $15000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $15000.0, marking a year-over-year increase of 65000.0%. This contributed to the annual value of $1.7 million for FY2024, which is 2499.29% up from last year.
  • According to the latest figures from FY2024, Pediatrix Medical's Treasury Shares is $1.7 million, which was up 2499.29% from $1.4 million recorded in FY2023.
  • Pediatrix Medical's Treasury Shares' 5-year high stood at $4.5 million during FY2022, with a 5-year trough of $172000.0 in FY2021.
  • Its 5-year average for Treasury Shares is $1.6 million, with a median of $1.4 million in 2023.
  • In the last 5 years, Pediatrix Medical's Treasury Shares tumbled by 9072.25% in 2020 and then soared by 254186.05% in 2022.
  • Over the past 5 years, Pediatrix Medical's Treasury Shares (Annual) stood at $470000.0 in 2020, then tumbled by 63.4% to $172000.0 in 2021, then soared by 2541.86% to $4.5 million in 2022, then plummeted by 70.13% to $1.4 million in 2023, then increased by 24.99% to $1.7 million in 2024.
  • Its last three reported values are $1.7 million in FY2024, $1.4 million for FY2023, and $4.5 million during FY2022.